Rhythm Pharmaceuticals' IPO

Rhythm Pharmaceuticals raised a round of funding on October 05, 2017. Investors include Public.

Rhythm Pharmaceuticals is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm is developing the ghrelin peptide agonist, RM-131, for the trea…

Articles about Rhythm Pharmaceuticals' IPO: